South African Tuberculosis Vaccine Initiative (SATVI) CRS

Location	IDMM, Faculty of Health Science, UCT, Anzio Road, Observatory Cape Town, Western Cape, Western Province 7705 South Africa
CRS Coordinator	Willem Christoff Hikuam chris.hikuam@uct.ac.za 27-4066228
CRS Leader	Mark Hatherill mark.hatherill@uct.ac.za 27-21-4066791
Studies	A5343: A Trial of the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, among Participants Taking Multidrug Treatment for Drug-Resistant Pulmonary Tuberculosis A5300B:Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Participants (PHOENIx) A5372: Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals (RPT-DTG PK Study)